Thioguanine Clinical Trials
7 actively recruiting trials across 4 locations
Also known as: 2-Amino 6MP, 2-Amino-1,7-dihydro-6H-purine-6-thione, 2-Amino-6-mercaptopurine, 2-Amino-6-purinethiol, 2-Aminopurin-6-thiol, 2-Aminopurine-6(1H)-thione, 2-Aminopurine-6-thiol, 2-Aminopurine-6-thiol Hemihydrate, 2-Mercapto-6-aminopurine, 6-Amino-2-mercaptopurine, 6-Mercapto-2-aminopurine, 6-Mercaptoguanine, 6-TG, 6-thioguanine, 6H-Purine-6-thione, 2-amino-1,7-dihydro- (9CI), BW 5071, Lanvis, Tabloid, Tabloid®, Thioguanine Hemihydrate, Thioguanine Hydrate, Tioguanin, Tioguanine, WR-1141, Wellcome U3B, X 27
Birmingham, Alabama3 trials
Children's Hospital of Alabama
Other1 trial
San Diego, California1 trial
Chicago, Illinois1 trial
University of Chicago Medical Center
Tulsa, Oklahoma1 trial
Saint Francis Children's Hospital
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.